EGFR/HER2-IN-9 is a potent dual inhibitor of EGFR (IC50 = 3.2 nM) and HER2 (IC50 = 14 nM), which also effectively targets the EGFR T790M resistance mutation (IC50 = 8.3 nM). This compound is a valuable research tool for investigating oncogenic signaling in vitro and has shown antitumor efficacy in preclinical cancer models, including non-small cell lung cancer.
Molekulargewicht:
513.95
CAS Nummer:
[1637253-79-2]
Formel:
C25H25ClFN5O4
Target-Kategorie:
Others,EGFR
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten